Gastrointestinal Neoplasms  >>  luminespib (AUY922)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
luminespib (AUY922) / Ligand
NCT01404650: Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor

Completed
2
25
US
AUY922
SCRI Development Innovations, LLC, Novartis
Gastrointestinal Stromal Tumor
02/15
02/15

Download Options